Your browser doesn't support javascript.
loading
Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials.
Witlox, Willem J A; Ramaekers, Bram L T; Lacas, Benjamin; Pechoux, Cecile Le; Sun, Alexander; Wang, Si-Yu; Hu, Chen; Redman, Mary; van der Noort, Vincent; Li, Ning; Guckenberger, Matthias; van Tinteren, Harm; Groen, Harry J M; Joore, Manuela A; De Ruysscher, Dirk K M.
  • Witlox WJA; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre (MUMC), The Netherlands; Department of Radiation Oncology (Maastro Clinic), Maastricht University Medical Centre (MUMC), The Netherlands. Electronic address: willem.witlox@mumc.nl.
  • Ramaekers BLT; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre (MUMC), The Netherlands.
  • Lacas B; Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France.
  • Pechoux CL; Department of Radiation Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, France.
  • Sun A; Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Canada.
  • Wang SY; Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Hu C; NRG Oncology Statistics and Data Management Center, Philadelphia, United States; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, United States.
  • Redman M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States.
  • van der Noort V; Department of Biometrics, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.
  • Li N; Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland.
  • van Tinteren H; Trial and Data Center, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Groen HJM; Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, The Netherlands.
  • Joore MA; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre (MUMC), The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, The Netherlands.
  • De Ruysscher DKM; Department of Radiation Oncology (Maastro Clinic), Maastricht University Medical Centre (MUMC), The Netherlands.
Radiother Oncol ; 164: 163-166, 2021 11.
Article en En | MEDLINE | ID: mdl-34619235
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Carcinoma de Pulmón de Células no Pequeñas / Intervención Coronaria Percutánea / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Carcinoma de Pulmón de Células no Pequeñas / Intervención Coronaria Percutánea / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article